MIS416 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "MIS416" in English language version.

refsWebsite

Global rank English rank

4worldcat.org

5^th place

4nih.gov

4^th place

3doi.org

2^nd place

1springer.com

274^th place

309^th place

1nationalmssociety.org

low place

1clinicaltrials.gov

5,225^th place

4,062^nd place

1harvard.edu

18^th place

17^th place

1semanticscholar.org

11^th place

8^th place

1cbsnews.com

108^th place

80^th place

1biopharmadive.com

low place

biopharmadive.com

LaMotta, Lisa (June 27, 2017). "Innate becomes the latest loser in MS". BioPharma Dive. Retrieved August 8, 2018.

cbsnews.com

"New York Congressman Chris Collins indicted on insider trading charges". CBS News. 8 August 2018. Retrieved 29 August 2018.

clinicaltrials.gov

"Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis". United States National Library of Medicine. 28 August 2014. Retrieved 29 August 2018.

doi.org

Shirani, Afsaneh; Okuda, Darin T.; Stüve, Olaf (2016). "Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis". Neurotherapeutics. 13 (1): 58–69. doi:10.1007/s13311-015-0409-z. ISSN 1933-7213. PMC 4720678. PMID 26729332.
Brüggemann, Holger; Henne, Anke; Hoster, Frank; Liesegang, Heiko; Wiezer, Arnim; Strittmatter, Axel; Hujer, Sandra; Dürre, Peter; Gottschalk, Gerhard (30 July 2004). "The Complete Genome Sequence of Propionibacterium Acnes, a Commensal of Human Skin". Science. 305 (5684): 671–673. Bibcode:2004Sci...305..671B. doi:10.1126/science.1100330. ISSN 0036-8075. PMID 15286373. S2CID 26252335.
Girvan, Rebecca C.; Knight, Deborah A.; o'Loughlin, Chris J.; Hayman, Colin M.; Hermans, Ian F.; Webster, Gill A. (10 January 2011). "MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity". Vaccine. 29 (3): 545–557. doi:10.1016/j.vaccine.2010.10.040. ISSN 0264-410X. PMID 21034827.

harvard.edu

ui.adsabs.harvard.edu

Brüggemann, Holger; Henne, Anke; Hoster, Frank; Liesegang, Heiko; Wiezer, Arnim; Strittmatter, Axel; Hujer, Sandra; Dürre, Peter; Gottschalk, Gerhard (30 July 2004). "The Complete Genome Sequence of Propionibacterium Acnes, a Commensal of Human Skin". Science. 305 (5684): 671–673. Bibcode:2004Sci...305..671B. doi:10.1126/science.1100330. ISSN 0036-8075. PMID 15286373. S2CID 26252335.

nationalmssociety.org

"Results Announced from Phase 2 Trial of MIS416". National Multiple Sclerosis Society. 27 June 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

Shirani, Afsaneh; Okuda, Darin T.; Stüve, Olaf (2016). "Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis". Neurotherapeutics. 13 (1): 58–69. doi:10.1007/s13311-015-0409-z. ISSN 1933-7213. PMC 4720678. PMID 26729332.
Brüggemann, Holger; Henne, Anke; Hoster, Frank; Liesegang, Heiko; Wiezer, Arnim; Strittmatter, Axel; Hujer, Sandra; Dürre, Peter; Gottschalk, Gerhard (30 July 2004). "The Complete Genome Sequence of Propionibacterium Acnes, a Commensal of Human Skin". Science. 305 (5684): 671–673. Bibcode:2004Sci...305..671B. doi:10.1126/science.1100330. ISSN 0036-8075. PMID 15286373. S2CID 26252335.
Girvan, Rebecca C.; Knight, Deborah A.; o'Loughlin, Chris J.; Hayman, Colin M.; Hermans, Ian F.; Webster, Gill A. (10 January 2011). "MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity". Vaccine. 29 (3): 545–557. doi:10.1016/j.vaccine.2010.10.040. ISSN 0264-410X. PMID 21034827.

ncbi.nlm.nih.gov

Shirani, Afsaneh; Okuda, Darin T.; Stüve, Olaf (2016). "Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis". Neurotherapeutics. 13 (1): 58–69. doi:10.1007/s13311-015-0409-z. ISSN 1933-7213. PMC 4720678. PMID 26729332.

semanticscholar.org

api.semanticscholar.org

Brüggemann, Holger; Henne, Anke; Hoster, Frank; Liesegang, Heiko; Wiezer, Arnim; Strittmatter, Axel; Hujer, Sandra; Dürre, Peter; Gottschalk, Gerhard (30 July 2004). "The Complete Genome Sequence of Propionibacterium Acnes, a Commensal of Human Skin". Science. 305 (5684): 671–673. Bibcode:2004Sci...305..671B. doi:10.1126/science.1100330. ISSN 0036-8075. PMID 15286373. S2CID 26252335.

springer.com

adisinsight.springer.com

"Drug Profile: MIS 416". adisinsight.springer.com. 27 June 2018. Retrieved 29 August 2018.

worldcat.org

search.worldcat.org

"Innate Immunotherapeutics: Acne Offers Real Hope for MS Treatment". Australasian Biotechnology. 23 (3): 55. October 2013. ISSN 1036-7128.
Shirani, Afsaneh; Okuda, Darin T.; Stüve, Olaf (2016). "Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis". Neurotherapeutics. 13 (1): 58–69. doi:10.1007/s13311-015-0409-z. ISSN 1933-7213. PMC 4720678. PMID 26729332.
Brüggemann, Holger; Henne, Anke; Hoster, Frank; Liesegang, Heiko; Wiezer, Arnim; Strittmatter, Axel; Hujer, Sandra; Dürre, Peter; Gottschalk, Gerhard (30 July 2004). "The Complete Genome Sequence of Propionibacterium Acnes, a Commensal of Human Skin". Science. 305 (5684): 671–673. Bibcode:2004Sci...305..671B. doi:10.1126/science.1100330. ISSN 0036-8075. PMID 15286373. S2CID 26252335.
Girvan, Rebecca C.; Knight, Deborah A.; o'Loughlin, Chris J.; Hayman, Colin M.; Hermans, Ian F.; Webster, Gill A. (10 January 2011). "MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity". Vaccine. 29 (3): 545–557. doi:10.1016/j.vaccine.2010.10.040. ISSN 0264-410X. PMID 21034827.